Skip to Main Content

SalivaDirect™ COVID-19 Testing Process

COVID-19 testing process, SalivaDirect™ and receiving recent FDA authorization

Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization

The Pathology Clinical Molecular Diagnostic Lab, Directed by Dr. Pei Hui, has been authorized by FDA to test Covid-19 using saliva specimen as part of the FDA EUA, Led by Nate Grubaugh and Anne Wyllie, Yale School of Public Health. This lab would be the first laboratory to offer this test in the coming days. Congratulations to Dr. Pei Hui's leadership for this great achievement and thank the entire team for their efforts and contributions! This success represents an example of how our pathology clinical laboratory can closely collaborate with basic scientists to rapidly bring research to clinical diagnosis.

To Learn More About Partnering with Yale Pathology Labs on SalivaDirect™ Testing

Contact: Stephanie Weirsman, Physician Liaison, Yale Medicine Pathology

ph: 203-464-5518, cell: 203-464-5518

Yale Pathology Labs: